SCIEX Announces New Biotransformation Solutions for Routine and Comprehensive Metabolism and Biologic Catabolism Studies

January 24, 2017 FRAMINGHAM, MA — SCIEX , a global leader in life science analytical technologies, today announced their latest solution in the X-Series Quadrupole Time of Flight (QTOF) mass spectrometry (MS) platform. The newest X-Series model, the X500B QTOF System, brings simplicity, high-performance, and robustness for biotherapeutic analyses to one of the most compact... Read more

SCIEX Launches New Fast Glycan Labeling and Analysis Kit for Comprehensive Biopharmaceutical Characterization

Solution offers research analysts the power to detect changes in glycosylation in a fraction of the time as traditional methods January 24, 2017 Framingham, MA — SCIEX, a global leader in life science analytical technologies, today announced the launch of the new Fast Glycan Labeling and Analysis Kit for quantitative glycan analysis in biopharmaceutical characterization.... Read more

One of the World’s fastest metals analyser Vulcan, launched by Oxford Instruments

One of the World’s fastest metals analyser Vulcan, launched by Oxford Instruments 24 January 2017 Oxford Instruments has launched Vulcan, one of the fastest metals analyser with advanced reporting tools on the market. Vulcan is an ergonomic, balanced handheld LIBS (Laser Induced Breakdown Spectroscopy) analyser with a simple user interface. Vulcan has been designed for... Read more

Enzo Life Sciences Launches New Compound Library to Provide Essential Standards for Cancer Inhibitor Screening

Enzo Life Sciences is proud to introduce the SCREEN-WELL® Cancer Library, a collection of 275 ready-to-use compounds for use in cancer inhibitor screening and assay development. The SCREEN-WELL® Cancer Library is comprised of compounds that are dissolved at 10 mM in DMSO and aliquoted at 100 µL per well in deep 96-well plates. It contains... Read more

908 Devices Strengthens Life Science Leadership Team and Unveils Transformational Advancements to ZipChip

01.18.17 Life Sciences 908 Devices, a pioneer of purpose-built analytical devices for chemical and biomolecule analysis, today announced significant product enhancements for ZipChip™, an innovative system that provides high-quality separation capabilities as a front-end for mass spectrometry (MS). An integrated autosampler, built-in chip recognition intelligence and application specific assay kits are being released to radically... Read more

Irvine Scientific Introduces PRIME-XV® T Cell CDM for Immunotherapy Applications

Jan 16, 2017 | Posted in Cell Therapy The first chemically-defined, animal component-free, cell culture medium for T cells SANTA ANA, California – January 17, 2017: Irvine Scientific, a worldwide leader in cell culture media development and manufacturing, today announced the introduction of PRIME-XV® T Cell CDM, the first commercially available chemically-defined, animal component-free medium... Read more

Extending Ultrasound’s Impact: GE Healthcare’s New Vscan Extend Empowers Clinicians in Critical Moments

London – 11 January 2017 – Bringing ultrasound care into every setting in any environment  around the globe1, GE Healthcare today unveiled its new generation of pocket-sized, dual-probe ultrasound, the Vscan Extend™2. From the hospital and ambulance to more rural environments1, Vscan Extend™ uses incredible image quality and wireless connectivity3  to help users increase clinical... Read more

Illumina and Bio-Rad Launch Solution for Single-Cell Genomic Sequencing to Enable Robust Study of Complex Diseases

SAN DIEGO and HERCULES, Calif. — January 9, 2017 — Illumina, Inc. (NASDAQ: ILMN) and Bio‑Rad Laboratories, Inc. (NYSE: BIO)(NYSE: BIOb) today announced the launch of the Illumina® Bio-Rad® Single-Cell Sequencing Solution at the J.P. Morgan Healthcare Conference, San Francisco. The comprehensive solution is the first next-generation sequencing (NGS) workflow for single-cell analysis, providing researchers... Read more

Pacific Biosciences Improves Key Applications on the Sequel System with New Chemistry and Software Release

Monday, January 9, 2017 MENLO PARK, Calif., Jan. 09, 2017 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB) today announced a new version of chemistry (V2) and software (V4) for the Sequel™ System. The new release improves the system’s ability to support important applications such as structural variant detection and targeted sequencing—including metagenomics, minor... Read more

UPDATE — Pacific Biosciences Improves Key Applications on the Sequel System with New Chemistry and Software Release

MENLO PARK, Calif., Jan. 09, 2017 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB) today announced a new version of chemistry (V2) and software (V4) for the Sequel™ System. The new release improves the system’s ability to support important applications such as structural variant detection and targeted sequencing—including metagenomics, minor variant detection and isoform... Read more